The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients.

Eman Abd El Razek AbbasAhmed Barakat BarakatMohamed HassanySamar Samir Youssef

Published in: Journal, genetic engineering & biotechnology (2022)

We detected about 14% gain in BCL9 copy number in Egyptian HCC patients. But the variation in copy number of the BCL9 gene did not affect HCC development in our patients' cohort.

Keyphrases

copy number
end stage renal disease
ejection fraction
mitochondrial dna
chronic kidney disease
newly diagnosed
genome wide
peritoneal dialysis
prognostic factors
dna methylation
transcription factor